BeiGene, Ltd. anticipated opening of biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.1 USD | +0.37% |
|
-3.98% | -13.45% |
06-20 | Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing | MT |
06-17 | BeiGene, Ltd.(SHSE:688235) added to Shanghai Stock Exchange Health Care Sector Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.45% | 16.45B | |
+15.19% | 121B | |
+19.91% | 114B | |
+18.40% | 23.61B | |
-19.80% | 20.43B | |
-15.66% | 16.55B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B | |
+119.39% | 10.96B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024